Drugs that contain Mitomycin

1. Drug name - JELMYTO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9950069 UROGEN PHARMA Material and method for treating internal cavities Jan, 2031

(8 years from now)

US9040074 UROGEN PHARMA Material and method for treating internal cavities Jan, 2031

(8 years from now)

Treatment: NA

Dosage: POWDER;PYELOCALYCEAL

More Information on Dosage
Strength Dosage Availability
40MG/VIAL POWDER;PYELOCALYCEAL Prescription

2. Drug name - MITOSOL

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9539241 MOBIUS THERAP Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application
Jan, 2028

(5 years from now)

EP2046653A2 MOBIUS THERAP Apparatus And Method For Reconstituting A Pharmaceutical And Preparing The Reconstituted Pharmaceutical For Transient Application
Jul, 2027

(4 years from now)

EP2046653B1 MOBIUS THERAP Apparatus And Method For Reconstituting A Pharmaceutical And Preparing The Reconstituted Pharmaceutical For Transient Application
Jul, 2027

(4 years from now)

EP2046653A4 MOBIUS THERAP Apparatus And Method For Reconstituting A Pharmaceutical And Preparing The Reconstituted Pharmaceutical For Transient Application
Jul, 2027

(4 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9205075 MOBIUS THERAP Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application Jul, 2026

(3 years from now)

US8186511 MOBIUS THERAP Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application Jul, 2026

(3 years from now)

US7806265 MOBIUS THERAP Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application Feb, 2029

(6 years from now)

US9649428 MOBIUS THERAP Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application May, 2029

(6 years from now)

Treatment: Mitosol is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery. it is intended for topical application to the site of glaucoma filtration surgery

Dosage: FOR SOLUTION;TOPICAL

More Information on Dosage
Strength Dosage Availability
0.2MG/VIAL FOR SOLUTION;TOPICAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.